Biologically-Active Medical Devices Manufactured from Blood Plasma

Carmell Therapeutics is developing biologically-active medical devices, with growth and regenerative factors designed by nature in the right proportions to heal tissues.

News

1/13/15   Research Notebook: Carmell Therapeutics’ PBMs—A new paradigm for healing tissue and bone   The Link, the magazine of the Carnegie Mellon University School of Computer Science, has just published an article on Carmell's technology: Carmell Th[...]
12/23/14   Carmell Therapeutics Ends 2014 with Addition of a New Patent to its Growing Portfolio   December 23, 2014 – Pittsburgh, PA – Carmell Therapeutics, a company developing novel products manufactured from blood plasma, today announced the[...]
11/17/14   Pittsburgh researchers' bone putty could revolutionize how broken bones mend   Pittsburgh Tribune, Friday, Nov. 14, 2014 By Megha Satyanarayana Lisa Chapman describes her broken leg as possibly the worst pain she's ever felt [...]
10/9/14   Paper Describing Carmell Therapeutic’s Clinical Data Receives Coveted GT du Toit Award from the South African Orthopaedic Association   October 9, 2014 – Congress of the South African Orthopaedic Association (SAOA), Cape Town – Dr. David North, an orthopaedic trauma surgeon associa[...]